Y Inoue

The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.

Kazuhiko Tsutsumi, Y Inoue, Atsushi Shima et al. · Journal of Clinical Investigation · 1993 · 147 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Rapid and reversible inhibition by low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Heat and acid labile factors in low density lipoprotein mediate the inhibition.

Takako Tomita, Masanori Ezaki, Masao Miwa et al. · Circulation Research · 1990 · 56 citations · Full text

Medicine, Cardiology, Pharmacology +10

Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats

Kazuhiko Tsutsumi, Y Inoue, A. Shima et al. · Diabetes · 1995 · 23 citations

Life Sciences, Biochemistry, Pharmacology +17

Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid.

Hiroshi Fujisawa, Tomoo Nishimura, Y Inoue et al. · PubMed · 1990 · 11 citations

Medicine, Immunology, Pharmacology +17

Defective protein phosphorylation associated with hypofunctions in stroke-prone spontaneously hypertensive rat platelets.

Toshihiko Tomita, Masahiko Ikeda, Y Inoue et al. · Hypertension · 1989 · 10 citations

Life Sciences, Biochemistry, Physiology +17